Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.36% | 36.33% | -0.23% | 257.22% | -60.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.30% | 42.20% | 0.95% | 238.34% | -57.09% |
| Operating Income | -10.30% | -42.20% | -0.95% | -238.34% | 57.09% |
| Income Before Tax | -25.26% | -57.12% | 7.53% | -248.48% | 54.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.26% | -57.12% | 7.53% | -248.48% | 54.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.26% | -57.12% | 7.53% | -248.48% | 54.79% |
| EBIT | -10.30% | -42.20% | -0.95% | -238.34% | 57.09% |
| EBITDA | -10.19% | -42.54% | -0.73% | -242.34% | 57.29% |
| EPS Basic | -14.29% | -50.00% | 12.50% | -250.00% | 53.33% |
| Normalized Basic EPS | 0.00% | -50.00% | 0.00% | -200.00% | 50.00% |
| EPS Diluted | -14.29% | -50.00% | 12.50% | -250.00% | 53.33% |
| Normalized Diluted EPS | 0.00% | -50.00% | 0.00% | -200.00% | 50.00% |
| Average Basic Shares Outstanding | 6.00% | 4.74% | 4.05% | 2.88% | 0.88% |
| Average Diluted Shares Outstanding | 6.00% | 4.74% | 4.05% | 2.88% | 0.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |